Grace Therapeutics, Inc. (GRCE) Q1 2024 Annual Earnings
GRCE·Reported June 21, 2024·Before market open
Diluted EPS came in at $-0.18, beat the $-0.35 consensus by $0.17.
Diluted EPS
$-0.18beat by $0.17
Consensus: $-0.35
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Grace Therapeutics, Inc.'s Q1 2024 earnings report.
Grace Therapeutics, Inc. (GRCE) reported Q1 2024 earnings on June 21, 2024 before market open.
Grace Therapeutics, Inc. reported diluted EPS of $-0.18 for Q1 2024.
EPS beat the consensus estimate of $-0.35 by $0.17.
You can read the 10-K periodic report (0000950170-24-075875) directly on SEC EDGAR. The filing index links above go to sec.gov.